Postoperative brain radiotherapy: Role of stereotactic radiotherapy;Radiothérapie cérébrale postopératoire: Indication de l'irradiation en conditions stéréotaxiques

Cancer/Radiotherapie

Volumn 17, Issue 5-6, 2013, Pages 407-412

  Thillays, F ^a   Dore M ^a   Martin, S A ^b  

^a UMR INSERM U892 CNRS 6299   (France)

^b CHU de Nantes   (France)

Author keywords

Brain metastasis; Radiosurgery; Radiotherapy; Stereotaxy

Indexed keywords

BRAIN METASTASIS; CANCER RADIOTHERAPY; HEALTH CARE QUALITY; HUMAN; POSTOPERATIVE CARE; PRIORITY JOURNAL; SHORT SURVEY; STEREOTACTIC TREATMENT;

BRAIN METASTASIS; MÉTASTASES CÉRÉBRALES; RADIOCHIRURGIE; RADIOSURGERY; RADIOTHÉRAPIE; RADIOTHERAPY; STÉRÉOTAXIE; STEREOTAXY;

BRAIN NEOPLASMS; CRANIAL IRRADIATION; HUMANS; NEUROPSYCHOLOGICAL TESTS; RADIOSURGERY; RADIOTHERAPY, ADJUVANT; RANDOMIZED CONTROLLED TRIALS AS TOPIC;

EID: 84884304751     PISSN: 12783218     EISSN: 17696658     Source Type: Journal    
DOI: 10.1016/j.canrad.2013.07.134     Document Type: Short Survey

References (44)

1. Chao J.H., Phillips R., Nickson J.J. Roentgen-ray therapy of cerebral metastases. Cancer 1954, 7:682-689.
2. Delattre J.Y., Krol G., Thaler H.T., Posner J.B. Distribution of brain metastases. Arch Neurol 1988, 45:741-744.
3. Posner J.B. Management of central nervous system metastases. Semin Oncol 1977, 4:81-91.
4. Cox J.D., Yesner R.A. Adenocarcinoma of the lung: recent results from the Veterans Administration Lung Group. Am Rev Resp Dis 1979, 120:1025-1029.
5. Sperduto P.W. A review of stereotactic radiosurgery in the management of brain metastases. Technol Cancer Res Treat 2003, 2:105-110.
6. Tan T.C., Mc L.B.P. Image-guided craniotomy for cerebral metastases: techniques and outcomes. Neurosurgery 2003, 53:82-89. discussion 9-90.
7. Kondziolka D., Lunsford L.D. Intraoperative navigation during resection of brain metastases. Neurosurg Clin N Am 1996, 7:267-277.
8. Sperduto P.W., Berkey B., Gaspar L.E., Mehta M., Curran W. A new prognostic index and comparison to three other indices for patients with brain metastases: an analysis of 1,960patients in the RTOG database. Int J Radiat Oncol Biol Phys 2008, 70:510-514.
9. Korinth M.C., Delonge C., Hutter B.O., Gilsbach J.M. Prognostic factors for patients with microsurgically resected brain metastases. Onkologie 2002, 25:420-425.
10. Patel A.J., Suki D., Hatiboglu M.A., Abouassi H., Shi W., Wildrick D.M., et al. Factors influencing the risk of local recurrence after resection of a single brain metastasis. J Neurosurg 2010, 113:181-189.
11. Suki D., Abouassi H., Patel A.J., Sawaya R., Weinberg J.S., Groves M.D. Comparative risk of leptomeningeal disease after resection or stereotactic radiosurgery for solid tumor metastasis to the posterior fossa. J Neurosurg 2008, 108:248-257.
12. Patchell R.A., Tibbs P.A., Walsh J.W., Dempsey R.J., Maruyama Y., Kryscio R.J., et al. A randomized trial of surgery in the treatment of single metastases to the brain. N Eng J med 1990, 322:494-500.
13. Vecht C.J., Haaxma-Reiche H., Noordijk E.M., Padberg G.W., Voormolen J.H., Hoekstra F.H., et al. Treatment of single brain metastasis: radiotherapy alone or combined with neurosurgery?. Ann Neurol 1993, 33:583-590.
14. Mintz A.H., Kestle J., Rathbone M.P., Gaspar L., Hugenholtz H., Fisher B., et al. A randomized trial to assess the efficacy of surgery in addition to radiotherapy in patients with a single cerebral metastasis. Cancer 1996, 78:1470-1476.
15. Baumert B.G., Rutten I., Dehing-Oberije C., Twijnstra A., Dirx M.J., Debougnoux-Huppertz R.M., et al. A pathology-based substrate for target definition in radiosurgery of brain metastases. Int J Radiat Oncol Biol Phys 2006, 66:187-194.
16. Andrews D.W., Scott C.B., Sperduto P.W., Flanders A.E., Gaspar L.E., Schell M.C., et al. Whole-brain radiation therapy with or without stereotactic radiosurgery boost for patients with one to three brain metastases: phase III results of the RTOG 9508randomised trial. Lancet 2004, 363:1665-1672.
17. Aoyama H., Shirato H., Tago M., Nakagawa K., Toyoda T., Hatano K., et al. Stereotactic radiosurgery plus whole-brain radiation therapy vs stereotactic radiosurgery alone for treatment of brain metastases: a randomized controlled trial. JAMA 2006, 2483-2491.
18. Kondziolka D., Patel A., Lunsford L.D., Kassam A., Flickinger J.C. Stereotactic radiosurgery plus whole-brain radiotherapy versus radiotherapy alone for patients with multiple brain metastases. Int J Radiat Oncol Biol Phys 1999, 295:427-434.
19. Patchell R.A., Tibbs P.A., Regine W.F., Dempsey R.J., Mohiuddin M., Kryscio R.J., et al. Postoperative radiotherapy in the treatment of single metastases to the brain: a randomized trial. JAMA 1998, 45:1485-1489.
20. Kocher M., Soffietti R., Abacioglu U., Villa S., Fauchon F., Baumert B.G., et al. Adjuvant whole-brain radiotherapy versus observation after radiosurgery or surgical resection of one to three cerebral metastases: results of the EORTC 22952-26001study. J Clin Oncol 2011, 280:134-141. [PubMed PMID: 21041710].
21. Noël G., Simon J.M., Valéry C.A., Cornu P., Boisserie G., Ledu D., et al. Linac radiosurgery for brain metastasis of melanoma. Stereotact Funct Neurosurg 2002, 29:245-255.
22. Noël G., Valéry C.A., Boisserie G., Cornu P., Hasboun D., Marc Simon J., et al. LINAC radiosurgery for brain metastasis of renal cell carcinoma. Urol Oncol 2004, 22:25-31.
23. Meyers C.A. Neurocognitive dysfunction in cancer patients. Oncology 2000, 14:75-79. [discussion 9, 81-2, 5].
24. Aoyama H., Tago M., Kato N., Toyoda T., Kenjyo M., Hirota S., et al. Neurocognitive function of patients with brain metastasis who received either whole-brain radiotherapy plus stereotactic radiosurgery or radiosurgery alone. Int J Radiat Oncol Biol Phys 2007, 68:1388-1395.
25. Meyers C.A., Smith J.A., Bezjak A., Mehta M.P., Liebmann J., Illidge T., et al. Neurocognitive function and progression in patients with brain metastases treated with whole-brain radiation and motexafin gadolinium: results of a randomized phase III trial. J Clin Oncol 2004, 22:157-165.
26. Chang E.L., Wefel J.S., Hess K.R., Allen P.K., Lang F.F., Kornguth D.G., et al. Neurocognition in patients with brain metastases treated with radiosurgery or radiosurgery plus whole-brain irradiation: a randomised controlled trial. Lancet Oncol 2009, 10:1037-1044.
27. Iwai Y., Yamanaka K., Yasui T. Boost radiosurgery for treatment of brain metastases after surgical resections. Surg Neurol 2008, 69:181-186. [discussion 6].
28. Jarvis L.A., Simmons N.E., Bellerive M., Erkmen K., Eskey C.J., Gladstone D.J., et al. Tumor bed dynamics after surgical resection of brain metastases: implications for postoperative radiosurgery. Int J Radiat Oncol Biol Phys 2012, 84:943-948.
29. Kelly P.J., Lin Y.B., Yu A.Y., Alexander B.M., Hacker F., Marcus K.J., et al. Stereotactic irradiation of the postoperative resection cavity for brain metastasis: a frameless linear accelerator-based case series and review of the technique. Int J Radiat Oncol Biol Phys 2012, 82:95-101.
30. Do L., Pezner R., Radany E., Liu A., Staud C., Badie B. Resection followed by stereotactic radiosurgery to resection cavity for intracranial metastases. Int J Radiat Oncol Biol Phys 2009, 73:486-491.
31. Mathieu D., Kondziolka D., Flickinger J.C., Fortin D., Kenny B., Michaud K., et al. Tumor bed radiosurgery after resection of cerebral metastases. Neurosurgery 2008, 62:817-823. discussion 23-4.
32. Jagannathan J., Yen C.P., Ray D.K., Schlesinger D., Oskouian R.J., Pouratian N., et al. Gamma Knife radiosurgery to the surgical cavity following resection of brain metastases. J Neurosurg 2009, 111:431-438.
33. Nataf F., Schlienger M., Liu Z., Foulquier J.N., Gres B., Orthuon A., et al. Radiosurgery with or without a 2-mm margin for 93single brain metastases. Int J Radiat Oncol Biol Phys 2008, 70:766-772.
34. Noël G., Simon J.M., Valéry C.A., Cornu P., Boisserie G., Hasboun D., et al. Radiosurgery for brain metastasis: impact of CTV on local control. Radiother Oncol 2003, 68:15-21.
35. Shaw E., Scott C., Souhami L., Dinapoli R., Bahary J.P., Kline R., et al. Radiosurgery for the treatment of previously irradiated recurrent primary brain tumors and brain metastases: initial report of Radiation Therapy Oncology Group protocol (90-05). Int J Radiat Oncol Biol Phys 1996, 34:647-654.
36. Minniti G., Esposito V., Clarke E., Scaringi C., Lanzetta G., Salvati M., et al. Multidose stereotactic radiosurgery (9Gy×3) of the postoperative resection cavity for treatment of large brain metastases. Int J Radiat Oncol Biol Phys 2013, 86:623-629.
37. Kocher M., Maarouf M., Bendel M., Voges J., Muller R.P., Sturm V. Linac radiosurgery versus whole-brain radiotherapy for brain metastases. A survival comparison based on the RTOG recursive partitioning analysis. Strahlenther Onkol 2004, 180:263-267.
38. Soltys S.G., Adler J.R., Lipani J.D., Jackson P.S., Choi C.Y., Puataweepong P., et al. Stereotactic radiosurgery of the postoperative resection cavity for brain metastases. Int J Radiat Oncol Biol Phys 2008, 70:187-193.
39. Quigley M.R., Fuhrer R., Karlovits S., Karlovits B., Johnson M. Single session stereotactic radiosurgery boost to the postoperative site in lieu of whole-brain radiation in metastatic brain disease. J Neurooncol 2008, 87:327-332.
40. Karlovits B.J., Quigley M.R., Karlovits S.M., Miller L., Johnson M., Gayou O., et al. Stereotactic radiosurgery boost to the resection bed for oligometastatic brain disease: challenging the tradition of adjuvant whole-brain radiotherapy. Neurosurg Focus 2009, 27:E7.
41. Hwang S.W., Abozed M.M., Hale A., Eisenberg R.L., Dvorak T., Yao K., et al. Adjuvant Gamma Knife radiosurgery following surgical resection of brain metastases: a 9-year retrospective cohort study. J Neurooncol 2010, 98:77-82.
42. Noël G., Daisne J.F., Thillays F. Radiothérapie en conditions stéréotaxiques des métastases cérébrales. Cancer Radiother 2012, 16Suppl:S101-S110.
43. Braccini A.L., Azria D., Mazeron J.J., Mornex F., Jacot W., Metellus P., et al. Métastases cérébrales: quelle prise en charge en 2012?. Cancer Radiother. 2012, 16:309-314.
44. Bonnette P. Cancers bronchiques non à petites cellules avec oligométastases: prise en charge chirurgicale à visée curative. Cancer Radiother. 2012, 16:344-347.